Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Lymphoid leukemia, chronic (PheCode 204.12)

ACOXL · rs10202539

Strength of the evidence

2 / 4

Its strongest genetic-study result is p = 10−20, with 2 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 360 African American or Afro-Caribbean cases, 121,531 African American or Afro-Caribbean controls, 2,845 European ancestry cases, 448,087 European ancestry controls.

The effect Each copy of the G allele shifted the measure 0.257 lower (95% confidence interval 0.22-0.3); p = 4 × 10−21.

How common The G allele had a frequency of about 70% in the people studied.

Where it sits Chromosome 2, band 2q13 — in an intron of ACOXL.

How common each version is

AG
Korean KRGDB
A 22.3% · G 77.7%
Korean Korea4K
A 21.9% · G 78.1%
Japanese ToMMo
A 24.3% · G 75.7%
World gnomAD
A 27.4% · G 72.6%
World 1000 Genomes
A 22.9% · G 77.1%
World TOPMed
A 26.3% · G 73.7%

By ancestry gnomAD

East Asian
A 22.8% · G 77.2%
European (non-Finnish)
A 35.2% · G 64.8%
African / African American
A 11.3% · G 88.7%
South Asian
A 26.2% · G 73.9%
Admixed American (Latino)
A 28.5% · G 71.5%
Middle Eastern
A 34.4% · G 65.6%
Finnish
A 36.9% · G 63.1%
Ashkenazi Jewish
A 39.9% · G 60.1%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A No copy of the version the research linked to Lymphoid leukemia, chronic (PheCode 204.12). This is the starting point the study compared everyone against.
A/G One copy of the version the research linked to Lymphoid leukemia, chronic (PheCode 204.12). That is a smaller link than two copies.
G/G Two copies of the version the research linked to Lymphoid leukemia, chronic (PheCode 204.12). That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Lymphoid leukemia, chronic (PheCode 204.12) (rs10202539). MyGeneLog™. https://www.mygenelog.com/variants/rs10202539

← See all variants